Investor Relations
Investing on the future and betterment of mankind
Zenzic Labs looks for investors who share our vision in advancing humanity through game-changing stem cell technology, creating mass accessibility of iPSC to potentially combating today’s incurable diseases.
Our technology today will be a sustainable competitive advantage in the future, that will accelerate the industry as a whole. Learn more about our organisation and plan to create an informed decision on whether Zenzic Labs is the right investment avenue for you.
More Information
Due to the nature of the industry, we can only release the investor prospectus to parties that have signed an NDA with us. To get our investor prospectus, please contact us
Zenzic Labs has signed the partnership with A*Cellerate Singapore for the global exclusive license of several patents critical to operation, to read more, Download the article here.
Zenzic Labs has signed a LOI with Ternion Singapore to develop iPSC for Ternion. Download the article here.
Zenzic Labs has secured seed investment at USD 80 million valuation. Download the article here.
Schedule a conversation with our team members to understand more about Zenzic Labs and the investment opportunity.